Zhongzhi Pharmaceutical Holdings (3737.HK) Earnings Analysis
Zhongzhi Pharmaceutical Holdings (3737.HK) has no confirmed upcoming earnings date. Trailing P/E 26.52.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 3737.HK next report earnings?
No confirmed upcoming earnings date is currently scheduled for 3737.HK. This page updates as the calendar is published.
3737.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-08-23 | 0.1058 HKD | n/a | n/a | n/a |
3737.HK valuation and analyst view
| Trailing P/E | 26.52 |
|---|---|
| Trailing EPS | 0.02032 HKD |
| Price / book | 0.42 |
| Dividend yield | 0.00% |
| Market cap | 0.54B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Zhongzhi Pharmaceutical Holdings (3737.HK)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 3737.HK. This page updates as the calendar is published.
Did 3737.HK beat earnings last quarter?
Consensus estimate data was not available for 3737.HK's 2024-08-23 report.
What is 3737.HK's current P/E ratio and EPS?
3737.HK trades at a trailing P/E of 26.52 on trailing EPS of 0.0203224062658043 HKD.
What do analysts rate 3737.HK?
3737.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.